 A
stunning admission from a senior official of the pharmaceutical
giant GlaxoSmithKline has vindicated critics of the drug
industry. At a London conference last December, Dr. Allen
Roses, a senior vice president of GlaxoSmithKline candidly
admitted that most prescription drugs work only part of the
time, and in many instances less than HALF of the time!
Dr. Roses, one of the world's leading geneticists did not intend
his comments as a criticism of existing prescription drugs.
Rather, he was arguing for something called "pharmacogenomics,"
the use of human genetics to create "tailored" drugs for
patients with different genes. This method, he believes would
result in more effective pharmaceuticals and elimination of what
he calls the "trial and error" method of prescribing drugs
currently employed by most physicians.While his vision of a
future in which drugs are custom-designed for particular
patients or groups of patients may be intriguing, the notion of
physicians writing prescriptions by guess and by gosh is
chilling.
And how bad is the problem?
|
Click here to order
![[PRINT VERSION]](/brewer/icon_print_version.gif){kind=icon}
